Search research articles
Contact Us
Filters
Showing results (41-50 of 49) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 49 results.
The Lancet. Gastroenterology & Hepatology
|
December 22, 2022
Second-line levofloxacin-based quadruple therapy versus bismuth-based quadruple therapy for Helicobacter pylori eradication and long-term changes to the gut microbiota and antibiotic resistome: a multicentre, open-label, randomised controlled trial
Jyh-Ming Liou, Xiao-Tao Jiang, Chieh-Chang Chen, et al.
Lancet (London, England)
|
October 23, 2016
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
Jyh-Ming Liou, Yu-Jen Fang, Chieh-Chang Chen, et al.
Clinical and Molecular Hepatology
|
July 13, 2021
Sofosbuvir/velpatasvir plus ribavirin for Child-Pugh B and Child-Pugh C hepatitis C virus-related cirrhosis
Chen-Hua Liu, Chi-Yi Chen, Wei-Wen Su, et al.
Gut
|
January 7, 2021
Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment
Chen-Hua Liu, Chi-Yi Chen, Wei-Wen Su, et al.
Hepatology International
|
March 7, 2021
Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan
Chen-Hua Liu, Po-Yueh Chen, Jyh-Jou Chen, et al.
Hepatology International
|
January 26, 2023
Sofosbuvir/velpatasvir/voxilaprevir for patients with chronic hepatitis C virus infection previously treated with NS5A direct-acting antivirals: a real-world multicenter cohort in Taiwan
Chen-Hua Liu, Cheng-Yuan Peng, Chun-Jen Liu, et al.
Nature Communications
|
July 9, 2025
Clinical impact of pharmacogenetic risk variants in a large chinese cohort
Chun-Yu Wei, Ming-Shien Wen, Chih-Kuang Cheng, et al.
Nature
|
October 15, 2025
Population-specific polygenic risk scores for people of Han Chinese ancestry
Hung-Hsin Chen, Chien-Hsiun Chen, Ming-Chih Hou, et al.
Nature
|
October 15, 2025
The Taiwan Precision Medicine Initiative provides a cohort for large-scale studies
Hsin-Chou Yang, Pui-Yan Kwok, Ling-Hui Li, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 49) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 49 results.
The Lancet. Gastroenterology & Hepatology
|
December 22, 2022
Second-line levofloxacin-based quadruple therapy versus bismuth-based quadruple therapy for Helicobacter pylori eradication and long-term changes to the gut microbiota and antibiotic resistome: a multicentre, open-label, randomised controlled trial
Jyh-Ming Liou, Xiao-Tao Jiang, Chieh-Chang Chen, et al.
Lancet (London, England)
|
October 23, 2016
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
Jyh-Ming Liou, Yu-Jen Fang, Chieh-Chang Chen, et al.
Clinical and Molecular Hepatology
|
July 13, 2021
Sofosbuvir/velpatasvir plus ribavirin for Child-Pugh B and Child-Pugh C hepatitis C virus-related cirrhosis
Chen-Hua Liu, Chi-Yi Chen, Wei-Wen Su, et al.
Gut
|
January 7, 2021
Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment
Chen-Hua Liu, Chi-Yi Chen, Wei-Wen Su, et al.
Hepatology International
|
March 7, 2021
Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan
Chen-Hua Liu, Po-Yueh Chen, Jyh-Jou Chen, et al.
Hepatology International
|
January 26, 2023
Sofosbuvir/velpatasvir/voxilaprevir for patients with chronic hepatitis C virus infection previously treated with NS5A direct-acting antivirals: a real-world multicenter cohort in Taiwan
Chen-Hua Liu, Cheng-Yuan Peng, Chun-Jen Liu, et al.
Nature Communications
|
July 9, 2025
Clinical impact of pharmacogenetic risk variants in a large chinese cohort
Chun-Yu Wei, Ming-Shien Wen, Chih-Kuang Cheng, et al.
Nature
|
October 15, 2025
Population-specific polygenic risk scores for people of Han Chinese ancestry
Hung-Hsin Chen, Chien-Hsiun Chen, Ming-Chih Hou, et al.
Nature
|
October 15, 2025
The Taiwan Precision Medicine Initiative provides a cohort for large-scale studies
Hsin-Chou Yang, Pui-Yan Kwok, Ling-Hui Li, et al.
Page
of 5